In 2021, the Center for Drug Evaluation of the National Medical Products Administration (NMPA) in China approved 69 New Drug Applications (NDA) for innovative drugs, with more than half of all approvals granted to chemical drugs. A New Drug Application (NDA) is the mechanism through which pharmaceutical manufacturers propose that the regulatory body approve a new drug or biopharmaceutical for general use and sale.
Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2021, by drug type
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
Print the statistic including description and metadata.
Chart type
Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2021, by drug type
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Statista has been my savior on several occasions.
The site is easy to maneuver and the data is in a format that can
go right into a report or presentation.
Learn more about how Statista can support your business.
National Medical Products Administration. (June 1, 2022). Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2021, by drug type [Graph]. In Statista. Retrieved February 20, 2025, from https://www.statista.com/statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
National Medical Products Administration. "Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2021, by drug type." Chart. June 1, 2022. Statista. Accessed February 20, 2025. https://www.statista.com/statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
National Medical Products Administration. (2022). Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2021, by drug type. Statista. Statista Inc.. Accessed: February 20, 2025. https://www.statista.com/statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
National Medical Products Administration. "Number of New Drug Applications (Nda) for Innovative Drugs Granted Approval in China from 2018 to 2021, by Drug Type." Statista, Statista Inc., 1 Jun 2022, https://www.statista.com/statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
National Medical Products Administration, Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2021, by drug type Statista, https://www.statista.com/statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/ (last visited February 20, 2025)
Number of New Drug Applications (NDA) for innovative drugs granted approval in China from 2018 to 2021, by drug type [Graph], National Medical Products Administration, June 1, 2022. [Online]. Available: https://www.statista.com/statistics/1319953/china-number-of-new-drug-applications-of-innovative-drugs-approved/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.